Abstract:In recent years, multidrug-resistant pathogenic microorganisms (MDROs) have emerged as a severe threat to human health, exhibiting robust resistance to traditional antibiotics. This has created a formidable challenge in modern medicine as we grapple with limited options to combat these resilient bacteria. Despite extensive efforts by scientists to develop new antibiotics targeting these pathogens, the quest for novel antibacterial molecules has become increasingly arduous. Fortunately, nature offers a potential solution in the form of cationic antimicrobial peptides (AMPs) and their synthetic counterparts. AMPs, naturally occurring peptides, have displayed promising efficacy in fighting bacterial infections by disrupting bacterial cell membranes, hindering their survival and reproduction. These peptides, along with their synthetic mimics, present an exciting alternative in combating antibiotic resistance. They hold the potential to emerge as a formidable tool against MDROs, offering hope for improved strategies to protect communities. Extensive research has explored the diversity, history, and structure-properties relationship of AMPs, investigating their amphiphilic nature for membrane disruption and mechanisms of action. However, despite their therapeutic promise, AMPs face several documented limitations. Among these challenges, poor pharmacokinetic properties stand out, impeding the attainment of therapeutic levels in the body. Additionally, some AMPs exhibit toxicity and susceptibility to protease cleavage, leading to a short half-life and reduced efficacy in animal models. These limitations pose obstacles in developing effective treatments based on AMPs. Furthermore, the high manufacturing costs associated with AMPs could significantly hinder their widespread use. In this review, we aim to present experimental and theoretical insights into different AMPs, focusing specifically on antibacterial peptides (ABPs). Our goal is to offer a concise overview of peptide-based drug candidates, drawing from a wide array of literature and peer-reviewed studies. We also explore recent advancements in AMP development and discuss the challenges researchers face in moving these molecules towards clinical trials. Our main objective is to offer a comprehensive overview of current AMP and ABP research to guide the development of more precise and effective therapies for bacterial infections.

Antimicrobial Peptides towards Clinical Application—A Long History to Be Concluded

The Antimicrobial Peptides and Their Potential Clinical Applications.

Antimicrobial Peptides: A New Hope in Biomedical and Pharmaceutical Fields

Antimicrobial Peptides: Challenging Journey to the Pharmaceutical, Biomedical, and Cosmeceutical Use

Progress of Antimicrobial Peptides Research and Its Current Therapeutic Application

Overview on the Recent Study of Antimicrobial Peptides: Origins, Functions, Relative Mechanisms and Application

Recent advances in antimicrobial peptide-based therapy

Antimicrobial Peptides: Diversity, Mechanism of Action and Strategies to Improve the Activity and Biocompatibility In Vivo

Antimicrobial Peptides: From Design to Clinical Application

Advancements in peptide-based antimicrobials: A possible option for emerging drug-resistant infections

Clinical Applications of Antimicrobial Peptides (AMPs): Where do we Stand Now?

Development and Challenges of Antimicrobial Peptides for Therapeutic Applications

Antimicrobial Peptides: Design, Chemical Synthesis, Activity Evaluation, and Application

Biosynthesis, Bioactivity, Biotoxicity and Applications of Antimicrobial Peptides for Human Health

Antimicrobial Peptides as Effective Agents Against Drug-Resistant Pathogens

Antimicrobial Peptides and Proteins: From Nature’s Reservoir to the Laboratory and Beyond

Our Experience over 20 Years: Antimicrobial Peptides against Gram Positives, Gram Negatives, and Fungi

Antimicrobial Peptides and Their Applications in Biomedical Sector

Biochemistry, Mechanistic Intricacies, and Therapeutic Potential of Antimicrobial Peptides: An Alternative to Traditional Antibiotics

Antimicrobial peptides: mechanism of action, activity and clinical potential

Antimicrobial Peptides and Their Biomedical Applications: A Review